Siemens eyes digital pathology with BioImagene investment

Just caught this on Healthimaging.com.

“Siemens Venture Capital has invested in BioImagene, a provider of scalable digital pathology solutions, following a recent closing of a $26 million series D financing round led by Burrill & Company.

Additionally, Ajit Singh, PhD, from the Image and Knowledge Group of Siemens Healthcare was appointed CEO of BioImagene following the financing round.

The Cupertino, Calif.-based BioImagene said it will use the investment to scale operations and accelerate the adoption of digital pathology with continued product development and expansion in the European and Asian markets.

BioImagene provides digital pathology solutions for acquiring, viewing, managing, analyzing, reporting and sharing images in the pathology laboratory. Additional investors in BioImagene include Ascension Health Ventures, Artiman Ventures, Burrill, ICCP Venture Partners and National Healthcare Services, the company said”

This

About Adam Chee

Health Informatician
This entry was posted in Blog - Health IT. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s